clinical trial · NCT02052882
Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
Isolated Chemotherapy-induced Thrombocytopeniaromiplostim
brief summary
This study is to determine if using weekly romiplostim injections will improve the patient's platelet count more effectively than simply waiting for the platelets to improve on its own, and if romiplostim will also allow the patient to receive at least 2 further cycles of chemotherapy without thrombocytopenia.
started
Jan 30, 2014
primary completion
Nov 13, 2023
completion
Nov 13, 2023
last updated
Dec 27, 2024
official title
An Open Label Phase II Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol